机构名称：
¥ 13.0
501 Fragrance Regulation 502 Tribally-Directed Precision Medicine Research 503 Unregulated Hemp-Derived Intoxicating Cannabinoids, and Derived Psychoactive Cannabis Products (DPCPs) 504 FDA Regulation of Biosimilars 505 Mitigating the Harms of Colorism and Skin Bleaching Agents 506 Screening for Image Manipulation in Research Publications 507 Ban on Dual Ownership, Investment, Marketing or Distribution of Recreational Cannabis by Medical Cannabis Companies 508 AMA to support regulations to decrease overdoses in children due to ingestion of edible cannabis 509 Addressing Sarcopenia and its Impact on Quality of Life 510 Study to investigate the validity of claims made by the manufacturers of OTC Vitamins, Supplements and “Natural Cures” 511 National Penicillin Allergy Day and Penicillin Allergy Evaluation & Appropriate Delabeling 512 AED位于513 Biotin补充包装免责声明的阿片类药物过量逆转代理
理事会的参考委员会E报告...
主要关键词
相关文件推荐
